Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy

Introduction: Hepatitis C virus (HCV), the leading cause of advanced liver disease, has enormous economic burden. Identification of patients at risk of treatment failure could lead to interventions that improve cure rates. Objectives: Our goal was to develop and evaluate a prediction model for HCV t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabulsi, Nadia A., Martin, Michelle T., Sharp, Lisa K., Koren, David E., Teply, Robyn, Zuckerman, Autumn, Lee, Todd A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751639/
https://www.ncbi.nlm.nih.gov/pubmed/33364936
http://dx.doi.org/10.3389/fphar.2020.551500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751639/
https://www.ncbi.nlm.nih.gov/pubmed/33364936
http://dx.doi.org/10.3389/fphar.2020.551500

Ejemplares similares